by Robert Hayes Posted on April 5, 2024April 5, 2024 BUSINESS BRIEF: Wilmington’s Charles River & Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration Read More
by Robert Hayes Posted on January 29, 2024January 29, 2024 BUSINESS BRIEF: Wilmington’s Charles River Laboratories Adds Reshema Kemps-Polanco To Board Of Directors Read More
by Robert Hayes Posted on July 26, 2023July 26, 2023 OBITUARY: Kathleen A. Murray, D.V.M, 68 Read More
by Robert Hayes Posted on May 30, 2023May 30, 2023 Wilmington’s Charles Rivers Labs Receives $1.47 Million In Job Creation Incentives From State, Will Create 98 New Jobs Read More
by Robert Hayes Posted on April 29, 2023April 29, 2023 Wilmington’s Charles River Labs Named A Top Ten Massachusetts Company For Gender Equity Among Executive Leadership Read More
by Robert Hayes Posted on February 23, 2023February 23, 2023 Wilmington’s Charles River Labs Under Federal Investigation Related To Importation Of Monkeys From Cambodia Read More
by Robert Hayes Posted on February 17, 2023February 17, 2023 Wilmington’s Charles River Laboratories & Purespring Therapeutics Announce Gene Therapy Manufacturing Collaboration Read More
by Robert Hayes Posted on February 2, 2023February 3, 2023 BUSINESS BRIEF: Wilmington’s Charles River Laboratories Acquires SAMDI Tech For $50 Million Read More
by Robert Hayes Posted on December 9, 2022December 9, 2022 Wilmington’s Charles River Labs Adds Craig Thompson, M.D. To Board of Directors Read More
by Robert Hayes Posted on October 19, 2022October 19, 2022 BUSINESS BRIEF: Wilmington’s Charles River and Nanoscope Therapeutics Announce Multifaceted Gene Therapy Manufacturing Partnership Read More
by Robert Hayes Posted on June 28, 2022June 28, 2022 BUSINESS BRIEF: Wilmington’s Charles River Laboratories Announces Opening of U.K. Manufacturing Facility Read More
You must be logged in to post a comment.